Unusual Neonatal Presentation of 48,XXYY

• by Jess Allerton

• February 10, 2026

FDA approves first therapy for warm autoimmune hemolytic anemia

The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.

• by Kathryn Wighton

• August 25, 2026

• 3 min

A pretreatment multiphasic CT-based decision-support model for differentiating pediatric hepatoblastoma from focal nodular hyperplasia

• by Lizhu Cai, Yun Peng

• August 24, 2026

FDA authorizes continuous ketone monitor

Patients aged 2 years and older with diabetes are eligible to use the wearable.

• by Kathryn Wighton

• August 26, 2026

• 2 min